Developmental and Epileptic Encephalopathy clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for

  • LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)

    open to eligible people ages 2-65

    This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DEE. The study consists of 3 main phases: Screening, Titration period, Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 24 months.

    San Francisco 5391959, California 5332921 and other locations

  • Evaluate How Safe and Tolerable NBI-921352 is as an Adjunctive Therapy for Participants With SCN8A-DEE

    Sorry, in progress, not accepting new patients

    Extension study to evaluate how safe and tolerable the drug NBI-921352 is when used as adjunctive therapy in participants with SCN8A developmental and epileptic encephalopathy syndrome (SCN8A-DEE).

    San Francisco 5391959, California 5332921 and other locations

Last updated: